This study was conducted to investigate the incremental prognostic value of sequential use of single-photon emission computed tomography (SPECT) and coronary computed tomography angiography (CCTA) in patients with suspected coronary artery disease (CAD).
Introduction
Non-invasive imaging tests play a vital role for the diagnosis and risk stratification in patients with suspected coronary artery disease (CAD). Functional tests detect the presence of myocardial ischaemia, provide important prognostic information and thus are widely used in clinical practice. 1 -3 However, functional tests do not provide anatomical information for targeted revascularization. 4, 5 In addition, the diagnostic accuracy of functional tests is often suboptimal, 4, 6 and non-contributory invasive coronary angiography (ICA) is not uncommon. 7 Coronary computed tomography angiography (CCTA) has shown appropriate temporal and spatial resolution, leading to excellent diagnostic accuracy for CAD. 8, 9 Also, its prognostic ability has been well described in recent several clinical studies and meta-analysis. 10 -13 However, because of the lack of information on haemodynamic significance, CCTA may be associated with more subsequent tests and related expenses when compared with functional tests. 14 Furthermore, coronary stenting for lesions without functional significance may increase cardiovascular events. 15 Therefore, complementary information from both anatomical and functional tests may be necessary for critical decision-making. In this regard, a standardized integrative strategy is needed to maximize the benefit of the multimodality imaging tests. In the present study, we evaluated the incremental prognostic value of sequential imaging of single-photon emission computed tomography (SPECT) and CCTA, and determined their potential synergic uses for optimizing the clinical assessment of patients with suspected CAD.
Methods

Study subjects
Study flow of enrolment process is shown in Figure 1 . A total of 1884 patients who underwent both CCTA and SPECT within 90 days, between November 2004 and January 2011, was retrospectively reviewed in three cardiac centres in Korea (Seoul National University Hospital and Seoul National University Boramae Medical Center in Seoul, and Seoul National University Bundang Hospital in Seongnam). Patients with any of the following criteria were excluded: (i) a previous history of CAD [myocardial infarction (MI) and/or revascularization] (n ¼ 516), (ii) inadequate CCTA image quality (n ¼ 11), and (iii) the lack of information on clinical parameters for study analyses (n ¼ 62). The remained 1295 patients were the subjects of the present study. The decision to perform both tests and the sequence of the tests was made by attending physicians. No cardiovascular events occurred between the two tests. Information on baseline clinical characteristics, including cardiovascular risk factors and type of symptoms, was obtained by reviewing patients' medical records. The pre-test probability of CAD was determined by age, sex and the nature of chest pain during initial presentation, 16 and classified as low (,10%), intermediate (10 -90%) , and high (.90%). The 10-year Framingham risk scores were estimated as previously described and classified as low (,10%), intermediate (10-20%) , and high (.20%). 17 The Institutional Review Boards of each hospital approved the study protocol and the requirement for informed consent was waived because of the retrospective study design.
CCTA protocols
All CCTAs were obtained using 64-slice CT scanners (Somatom Definition; Siemens Medical Solutions, Forchheim, Germany and Brilliance 64; Philips, Best, the Netherlands). Details of the CT scan protocol have been described in previous studies. 18, 19 Before CCTA, all the patients with an average heart rate of .65 b.p.m. received oral metoprolol 50 -100 mg in the absence of contraindications, and were given sublingual nitroglycerine 0.2-0.6 mg immediately before scanning. During image acquisition, 60 -80 mL of contrast was injected, followed by a saline flush. Helical scan data were obtained using the retrospective ECG-gating protocol.
Image acquisition was prescribed to include the coronary arteries, left ventricle, and proximal ascending aorta. All CCTA results were transferred to an external three-dimensional workstation and analysed independently by two experienced radiologists. The severity of luminal stenosis of the epicardial coronary artery was classified as 0 -49, 50 -69, 70 -89, or ≥90%. Patient-based analysis was performed.
SPECT protocols
Stress-rest MPI using Tc-99 m sestamibi and Tl-201 was performed with pharmacological stress. SPECT imaging was performed using an 1-day ECG-gated dual-isotope stress-rest protocol. 18, 20 Tl-201 was injected intravenously and a resting SPECT image was acquired. Afterward, pharmacological stress was induced by infusion of adenosine (0.14 mg/ kg/min for 6 min) (n ¼ 914, 70.6%) or dipyridamole (0.14 mg/kg/min for 4 min) (n ¼ 381, 29.4%). Tc-99 m sestabmibi was injected 3 min (for adenosine) or 7 min (for dipyridamole) after start of stress, and gated stress SPECT was performed 90 min after stress. SPECT images Figure 1 Study flow of patient enrollment. CAD, coronary artery disease; SPECT, single-photon emission computed tomography;
CCTA, coronary computed tomography angiography; AMI, acute myocardial infarction.
Sequential use of SPECT and CCTA were acquired using dual-head gamma cameras (Vertex EPIC, ADAC Laboratories, Milpitas, CA, USA). Short-and long-axis images were reconstructed using a Butterworth filter. Image interpretation was performed by two experienced nuclear cardiologists based on the semi-quantitative polar maps of perfusion, 21 using a 17-segment model. The perfusion defects from each segment were assessed on the stress image (segmental tracer activity, ,75% of maximum) and divided into reversible (≥10% increase in tracer uptake on the resting image) or persistent perfusion defects. 4, 18 In our study, both persistent and reversible perfusion defects were defined as abnormal MPI. 4, 21 The summed rest score (SRS) and the summed stress score (SSS) were calculated by adding together of the segmental perfusion score during rest and stress, respectively, and the summed difference score (SDS) was calculated by subtracting the SRS from the SSS. 5 The severity of ischaemia was classified by SSS: SSS 0, 1 -3, 4 -7 or ≥ 8, or SDS: SDS 0, 1-3, 4 -7, or ≥ 8. Patientbased analysis was performed.
Clinical events
The following events were regarded as clinical end points: cardiac death, non-fatal MI, unstable angina requiring admission and late (.90 days of CCTA and SPECT) revascularization. Patient follow-up data were gathered by two observers blinded to the results of CCTA and SPECT using hospital records (78.7%) or standardized telephone interviews (15.7%) for patients with a follow-up loss of more than recent 6 months. If a patient could not be reached even by a phone, information on death was obtained from the Korean Ministry of Public Administration and Security (5.6%). Sudden unexplained death was considered as cardiac death. MI was defined based on the following criteria: typical chest pain, elevated cardiac enzyme level, and typical changes in ECG. 22 Unstable angina was defined as acute chest pain regardless of the presence of ECG abnormalities and negative cardiac enzyme levels. 22 The first event was considered as the event of the patient. When two or more events were recorded at the same day, the most serious event was considered as the event of the patient in the following order: cardiac death, non-fatal MI, unstable angina, and revascularization. Patients with stable clinical features undergoing an early elective revascularization within 90 days after imaging with SPECT or CCTA were excluded from survival analysis.
5,10
Statistical analysis
Continuous variables were presented as mean + standard deviation (SD), and categorical variables were expressed as percentages. Continuous variables were compared using Student's t-test and categorical variables with the x 2 test. Proportions of patients who had a positive result of one test according to the results of the other test were categorically stratified, and compared using the x 2 test. Analysis of variance (ANOVA) with a post-hoc Bonferroni correction was used to compare the mean SSS or SDS between four groups stratified by stenosis severity on CCTA. The cumulative event free survival rates according to the results of SPECT and CCTA were compared using the Kaplan -Meier method with the log-rank test. Cox proportional hazards analysis was used to assess predictors of clinical events. Age, sex, body mass index (BMI), and a history of smoking status, diabetes, and hypertension were considered as confounders should be adjusted. The overall x 2 value was used for the quantification of the incremental prognostic value of SPECT and CCTA. A two-tailed P-value of ,0.05 was considered statistically significant. All data were analysed using SPSS for Windows 17.0 (Chicago, IL, USA).
Results
Study population
The baseline characteristics of the study patients are presented in The relationship between CCTA and SPECT
The time interval between the two imaging studies was median 13 days (inter-quartile range, 2-27 days). CCTA was first performed in 844 patients (64.4%). A total of 413 patients (31.9%) had abnormal MPI on SPECT, and 569 (43.9%) had a significant stenosis (≥50%) on CCTA. The relationship between the results of CCTA and SPECT is shown in Figure 2 . As stenosis severity on CCTA increased, the proportion of patients with abnormal MPI on SPECT increased (P , 0.001). When stenosis severities were 0-49, 50 -69, and 70 -89%, the proportions of abnormal MPI were 24.8, 31.2, and 37.2%, respectively. However, the proportion of patients with abnormal MPI increased dramatically to 70.3% when luminal stenosis was ≥90% ( Figure 2A with luminal stenoses of ,90% (P , 0.001 for each) ( Figure 2B ).
There was gradual increase of proportion of patients with significant stenosis (≥50%) on CCTA with an increase of the SSS on SPECT (P , 0.001) ( Figure 2C ). When the analysis was performed using SDS instead of the SSS, similar results were obtained: as luminal stenosis severity on CCTA increased, there was a gradual increase in the value of the SDS (P , 0.001) (Supplementary data online, Figure S1 ).
Incremental prognostic value of combined use of SPECT and CCTA
During the mean follow-up period of 795 + 566 days (median, 735 days), there were 7 cases of cardiac death (0.5%), 11 cases of non-fatal MI (0.8%), 75 cases of unstable angina (5.8%), and 20 cases of late revascularization (1.5%). There were 72 cardiovascular events (17.4%) in patients with perfusion defect, and 37 (4.2%) in patients without perfusion defect on SPECT (P , 0.001). There were 85 cardiovascular events (14.9%) in patients with significant stenosis (≥50%), and 24 cardiac events (3.3%) in patients without significant stenosis on CCTA (P , 0.001). The 1-year event rates were 15.7% (65/413) and 2.8% (25/882) in patients with and without perfusion defect (P , 0.001). The 1-year event rates were 13.0% (74/569) and 2.2% (16/726) in patients with and without significant stenosis (≥50%) on CCTA (P , 0.001). Cardiovascular events were significantly different according to the number of obstructed coronary arteries on CCTA (≥50%) in the Kaplan-Meier survival curve (log-rank; P , 0.001) (Supplementary data online, Figure S2 ). There was no correlation between the site of obstructive coronary arteries on CCTA (left anterior descending vs. left circumflex vs. right coronary artery) and clinical events among 339 patients who had one vessel disease on CCTA (log-rank; P ¼ 0.377). Among patients with events, patients without significant stenosis had a longer time to events than those with significant stenosis [324 + 340 days (median, 127 days) vs. 166 + 298 days (median, 42 days), P ¼ 0.047]. In patients without significant stenosis, the total follow-up duration was similar between those with and without events [766 + 558 days (median, 820 days) vs. 840 + 556 days (median, 792 days), P ¼ 0.518].
In multivariate Cox regression analysis, age ≥65 years [hazard ratio (HR), 1.70; 95% CI: 1.12-2.57; P ¼ 0.012], a history of hypertension (HR: 1.56; 95% CI: 1.05-2.33; P ¼ 0.028), significant stenosis (≥50%) on CCTA (HR: 3.20; 95% CI: 1.94-5.28, P , 0.001), and abnormal MPI on SPECT (HR: 3.32; 95% CI: 2.18-5.05; P , 0.001) were the independent predictors of cardiovascular events ( Table 2 ). The Kaplan -Meier curve for event free survival rates in study patients stratified by the results of SPECT and CCTA showed that combined Sequential use of SPECT and CCTA use of both imaging tests significantly improved prediction of the cardiovascular events (long-rank; P , 0.001) (Figure 3) . The incremental prognostic value of CCTA and SPECT over baseline clinical parameters including age, sex, BMI, smoking status, and a history of diabetes and hypertension were assessed using the overall The prognostic value of abnormal MPI was different according to the stenosis severity ( Table 3) . It was significant when patients had stenosis of 0-49% (HR: 5.91; 95% CI: 2.24 -15.61; P , 0.001), 50 -69% (HR: 2.68; 95% CI: 1.34-5.37; P ¼ 0.005), and 70-89% (HR: 3.74; 95% CI: 1.40-9.95; P ¼ 0.008), but it was not significant in stenosis of ≥90% (P ¼ 0.166). The prognostic value of CCTA was also different according to the SSS value ( Table 4) . It was significant in patients with SSS 0 (HR: 5.22; 95% CI: 2.14-12.72; P , 0.001) and 1-3 (HR: 2.85; 95% CI: 1.16-7.03; P ¼ 0.022) but not in SSS 4-7 and ≥8 (P . 0.05 for each). When the analysis was performed using the SDS instead of the SSS, the prognostic value of CCTA (≥50%) was significant in patients with SDS ¼ 0 (HR: 4.46; 95% CI: 2.04-9.76; P , 0.001) but not in patient with SDS ≥1 (P . 0.05 for each) (Supplementary data online, Table S1 ).
Information on the presence of ischaemia on SPECT had an incremental prognostic value to baseline clinical parameters in patients with 0-49% (overall x to 7.1; P ¼ 0.410) (Figure 6 ). When the analysis was performed using the SDS instead of the SSS, information on the significant stenosis (≥50%) on CCTA had an incremental prognostic value to clinical parameters in patients with SDS 0 (overall x 2 , 16.7 to 34.4; P , 0.001) and 1-3 (overall x 2 , 11.0 to 14.7; P ¼ 0.040) but not in patients with SDS 4-7 and ≥8 (P . 0.05 for each) on SPECT (Supplementary data online, Figure S3 ).
Discussion
In the present study, we demonstrated that the sequential use of SPECT and CCTA within 90 days had an incremental prognostic value for predicting future cardiovascular events in patients with suspected CAD. However, when there was a severe disease on either test, the incremental value of the other test was not evident; the prognostic value of SPECT was limited in patients with stenosis of ≥90% on CCTA, and the prognostic value of CCTA was limited in patients with SSS ≥ 4 on SPECT. These findings provide an important clue to establish an integrative strategy for risk stratification using CCTA and SPECT.
Though widely used, functional tests or anatomical tests have their own shortcomings in patients with CAD. Therefore, the strategy with combined use of functional and anatomical tests has received attention as an alternative. The prognostic value of anatomic imaging using the calcium score in relation to MPI results has been addressed. 23, 24 MPI provided incremental prognostic information over ICA. 25 A more recent study has shown that CCTA provided incremental prognostic value to MPI. 5 These results suggest the usefulness of the combined use of both tests in clinical practice. In addition, recent developments of hybrid SPECT/CT and positron emission tomography/computed tomography (PET/CT) systems enhanced the combined use of information. 26 -29 Fusion images provide additional diagnostic and prognostic information over stand-alone CCTA and MPI in patients with known or suspected CAD. 26 -29 However, routine application of sequential or the hybrid imaging techniques also presents several problems, such as radiation hazards and wastes of money and time. 27, 30 The present study is the largest to demonstrate the incremental prognostic value of the sequential use of SPECT and CCTA, and the first to address the prognostic value of SPECT and CCTA in relation to the results of the other one. The prognostic value of ischaemia on SPECT was limited in patients with severe luminal stenosis of ≥90% on CCTA. This is probably because most of the patients with stenosis of ≥90% have significant myocardial ischaemia as shown in our data (Figure 2A and B) and other stuides. 31, 32 On the other hand, the prevalence of ischaemia in patients with stenoses of ,90% on CCTA is relatively low (Figure 2A and B) , 31 and detection of ischaemia using SPECT is valuable in risk stratification in this group. The prognostic value of CCTA is limited in patient with SSS ≥4 on SPECT. This is in line with previous studies showing that SSS ≥4 on SPECT itself is a strong predictor of cardiovascular events. 5 Therefore, the additional prognostic value of CCTA may not be significant. The present study showed that SPECT had a significant prognostic power even in patients without significant CAD (,50% stenosis) on CCTA. Although patients had no significant luminal stenosis, 24.8% of the patients had a functional ischaemia on SPECT (Figure 2A ). This result is consistent with previous studies showing a big difference between the results of SPECT and CCTA. 4, 5 In addition, it may be related with the fact that patients with discrepancy between the initial test result, and clinical findings were more likely to be enrolled in the study because of our study design. Similarly, CCTA also had a significant prognostic power in patients without ischaemia (SSS ¼ 0) on SPECT. Substantial proportion of patients (38.2%) had a significant luminal stenosis (≥50%) on CCTA in patients with SSS ¼ 0 on SPECT ( Figure 2C) . It implies the prognostic importance of coronary stenosis without functional significance as previously demonstrated. 13 Annualized event rate of 2.2% in patients without significant stenosis is somewhat higher than previous studies, which is likely because Sequential use of SPECT and CCTA we included soft events such as unstable angina and revascularization. When only hard events including cardiac death and acute MI were considered as study end point, annualized event rate of this group was only 0.29%, which is in line with previous studies.
Taken together, we can suggest an integrative diagnostic strategy for patients with suspected CAD using CCTA and SEPCT: sequential testing of CCTA and SPECT has an additional value if initial CCTA reveals stenosis of 50 -89%, or initial SPECT reveals SSS ,4. Conversely, stenosis ≥90% on CCTA or SSS ≥4 on SPECT do not need further testing. We believe that this approach may be effective in risk stratification of patients with suspected CAD.
This study has several limitations. Firstly, our study population may not be the representative of common patients with suspected CAD because we enrolled only patients undergoing both CCTA and SPECT within 90 days. This is an inevitable limitation for retrospective analysis to demonstrate the incremental prognostic value of sequential use of the two tests. Secondly, test driven revascularization of some patients might be included in the study analyses although we excluded early revascularization within 90 days after tests. Thirdly, the indications for performing both non-invasive imaging tests could not be specified. Fourthly, majority of events was unstable angina that can be difficult to define exactly. Fifthly, we employed visual grading instead of automated quantification for the assessment of luminal stenosis. We believe that this approach is more useful in clinical settings. Lastly, we could not provide information regarding medical treatment that may have important impact on the prognosis.
In summary, the sequential use of SPECT and CCTA showed incremental prognostic value in patients with suspected CAD. However, additional benefit was not significant when CCTA revealed stenosis of ≥90% or SPECT revealed SSS ≥ 4. These results suggest an effective risk stratification strategy for patients with suspected CAD undergoing CCTA and SPECT.
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